Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin gets USFDA tentative nod for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension for HIV-1 infection

Ruchika Sharma24 Jan 2025 12:30 PM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...

Cipla Global CMO Rajeev Kumar Sinha resigns

Cipla Global Chief Manufacturing Officer Rajeev Kumar Sinha resigns

Ruchika Sharma24 Jan 2025 11:30 AM IST

Mumbai: Cipla has announced that Rajeev Kumar Sinha, Global Chief Manufacturing Officer and Senior Management Personnel of the Company has...

IT Dept searches offices, manufacturing facilities of Akums Drugs, its subsidiaries

Ruchika Sharma23 Jan 2025 3:42 PM IST

New Delhi: The Income Tax Department has searched the offices and manufacturing units of a contract development and manufacturing organisation...

Strides Pharma Science arm New York facility gets 4 USFDA observations

Laurus Labs US arm gets 1 USFDA observation

Ruchika Sharma23 Jan 2025 2:15 PM IST

Andhra Pradesh: Laurus Labs has announced that Laurus Generics Inc., a wholly-owned foreign subsidiary of the company, located in Berkeley...

Zydus Completes Agenus Deal, Launches US-Based Biologics CDMO Arm Zylidac Bio

Zydus Usnoflast gets USFDA Orphan Drug Designation for amyotrophic lateral sclerosis

Ruchika Sharma23 Jan 2025 1:15 PM IST

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration (USFDA) has granted...

RTI reveals 18 rabies deaths in Delhi over three years, contradicting Centre’s claim of ‘zero deaths’

Piramal Critical Care launches Chlorpromazine Hydrochloride for Injection in US

Ruchika Sharma23 Jan 2025 12:15 PM IST

Bethlehem: Piramal Critical Care (PCC), a division of Piramal Pharma Limited has announced the U.S. launch of Chlorpromazine Hydrochloride for...

Emcure Pharma inaugurates RnD centre in Gujarat

Ruchika Sharma23 Jan 2025 11:00 AM IST

Ahmedabad: Emcure Pharmaceuticals Limited has announced the inauguration of its state-of-the-art Formulation Research and Development (R&D) Centre...

Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case Study

Glenmark Life Sciences rebrands as Alivus Life Sciences

Ruchika Sharma22 Jan 2025 1:09 PM IST

Mumbai: Glenmark Life Sciences, a developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic...

Apollo Hospitals Pharmacy-Digital Demerger Is Strategic, Not Linked to Family Dispute, MD Clarifies

CCI approves merger of nine pharma entities with Sequent Scientific

Ruchika Sharma22 Jan 2025 11:57 AM IST

New Delhi: The Competition Commission of India has approved the proposed amalgamation of SRL, Viyash, Symed, Appcure, Vindhya Pharma, Vandana,...

JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLC

JnJ Spravato gets USFDA nod as monotherapy for adults with treatment-resistant depression

Ruchika Sharma22 Jan 2025 11:35 AM IST

Titusville: Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application...

Roquette seeks CCI nod for IFF Pharma solutions biz acquisition

Ruchika Sharma21 Jan 2025 4:15 PM IST

Roquette said that the deal would not pose competition concerns, given the limited market overlap and the presence of robust competitive constraints.

$GSK Blenrep combos receive positive EMA Committee opinion in relapsed/refractory multiple myeloma$

GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer

Ruchika Sharma21 Jan 2025 1:30 PM IST

London: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok